IGM BIOSCIENCES INC.

IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update

08 Nov 2024 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at Three Upcoming Investor Conferences

04 Nov 2024 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity

30 Sep 2024 15:01:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit

10 Sep 2024 15:05:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update

14 Aug 2024 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Jefferies Healthcare Conference

29 May 2024 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update

08 May 2024 15:10:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference

07 May 2024 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Refocusing of Sanofi Collaboration

17 Apr 2024 07:30:58 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum

10 Apr 2024 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

07 Mar 2024 15:10:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 Feb 2024 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 Jan 2024 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension

05 Dec 2023 15:01:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Third Quarter 2023 Financial Results

13 Nov 2023 15:10:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at Two Upcoming Investor Conferences

07 Nov 2023 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors

03 Oct 2023 15:05:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

06 Sep 2023 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Second Quarter 2023 Financial Results

03 Aug 2023 15:10:00 By Nasdaq GlobeNewswire

IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

03 Jul 2023 15:01:00 By Nasdaq GlobeNewswire